Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Jan;150(1):201–208.

Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia.

A Rashid 1, E S Pizer 1, M Moga 1, L Z Milgraum 1, M Zahurak 1, G R Pasternack 1, F P Kuhajda 1, S R Hamilton 1
PMCID: PMC1858511  PMID: 9006336

Abstract

Expression of the primary enzyme catalyzing the synthesis of fatty acids, ie, fatty acid synthase (FAS), and ex vivo fatty acid synthetic activity were examined in colorectal epithelium and neoplasms, including the relationship to tumor progression and prognosis. Immunohistochemistry for FAS showed only faint staining of native colorectal mucosa, but increased expression was found in all sporadic adenomas (n = 18), adenomas associated with familial adenomatous polyposis (n = 7), hyperplastic polyps (n = 3), dysplasias arising in ulcerative colitis (n = 17), and colorectal carcinomas (n = 130) including 11 with contiguous adenomas. The intensity of staining was strong in 53% of carcinomas, intermediate in 38%, and weak in 9%. Activity of the fatty acid synthetic pathway measured by labeling of six surgical specimens with [U-14C]acetate was 2- to 7-fold higher in colorectal carcinomas than adjacent native mucosa (P = 0.006) and 6- to 16-fold higher than serosal fat (P = 0.01). Activity correlated with immunohistochemical expression (Spearman's rank correlation coefficient = 0.85; P < 0.001). There was no statistically significant association between patient survival and FAS staining intensity of carcinomas. Our study shows that FAS is expressed in all colorectal neoplasms and there is a concomitant increase in fatty acid synthesis. FAS may therefore represent a potential therapeutic target.

Full text

PDF
201

Images in this article

204Figure 1
on p.204

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alo' P. L., Visca P., Marci A., Mangoni A., Botti C., Di Tondo U. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer. 1996 Feb 1;77(3):474–482. doi: 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  2. Amy C. M., Williams-Ahlf B., Naggert J., Smith S. Molecular cloning of the mammalian fatty acid synthase gene and identification of the promoter region. Biochem J. 1990 Nov 1;271(3):675–679. doi: 10.1042/bj2710675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bardi G., Pandis N., Fenger C., Kronborg O., Bomme L., Heim S. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res. 1993 Apr 15;53(8):1895–1898. [PubMed] [Google Scholar]
  4. Bradburn D. M., Gunn A., Hastings A., Shepherd N. A., Chapman P. D., Burn J. Histological detection of microadenomas in the diagnosis of familial adenomatous polyposis. Br J Surg. 1991 Nov;78(11):1394–1395. doi: 10.1002/bjs.1800781141. [DOI] [PubMed] [Google Scholar]
  5. Chalbos D., Chambon M., Ailhaud G., Rochefort H. Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem. 1987 Jul 25;262(21):9923–9926. [PubMed] [Google Scholar]
  6. Chalbos D., Escot C., Joyeux C., Tissot-Carayon M. J., Pages A., Rochefort H. Expression of the progestin-induced fatty acid synthetase in benign mastopathies and breast cancer as measured by RNA in situ hybridization. J Natl Cancer Inst. 1990 Apr 4;82(7):602–606. doi: 10.1093/jnci/82.7.602. [DOI] [PubMed] [Google Scholar]
  7. Chalbos D., Joyeux C., Escot C., Galtier F., Rochefort H. Progestin-induced fatty acid synthetase in breast cancer. From molecular biology to clinical applications. Ann N Y Acad Sci. 1990;595:67–73. doi: 10.1111/j.1749-6632.1990.tb34283.x. [DOI] [PubMed] [Google Scholar]
  8. Chalbos D., Joyeux C., Galtier F., Rochefort H. Progestin-induced fatty acid synthetase in human mammary tumors: from molecular to clinical studies. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):223–228. doi: 10.1016/0960-0760(92)90211-z. [DOI] [PubMed] [Google Scholar]
  9. Cho K. R., Vogelstein B. Genetic alterations in the adenoma--carcinoma sequence. Cancer. 1992 Sep 15;70(6 Suppl):1727–1731. doi: 10.1002/1097-0142(19920915)70:4+<1727::aid-cncr2820701613>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  10. Epstein J. I., Carmichael M., Partin A. W. OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology. 1995 Jan;45(1):81–86. doi: 10.1016/s0090-4295(95)96904-7. [DOI] [PubMed] [Google Scholar]
  11. Escot C., Joyeux C., Mathieu M., Maudelonde T., Pages A., Rochefort H., Chalbos D. Regulation of fatty acid synthetase ribonucleic acid in the human endometrium during the menstrual cycle. J Clin Endocrinol Metab. 1990 May;70(5):1319–1324. doi: 10.1210/jcem-70-5-1319. [DOI] [PubMed] [Google Scholar]
  12. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  13. Funabashi H., Kawaguchi A., Tomoda H., Omura S., Okuda S., Iwasaki S. Binding site of cerulenin in fatty acid synthetase. J Biochem. 1989 May;105(5):751–755. doi: 10.1093/oxfordjournals.jbchem.a122739. [DOI] [PubMed] [Google Scholar]
  14. Hamilton S. R. The molecular genetics of colorectal neoplasia. Gastroenterology. 1993 Jul;105(1):3–7. doi: 10.1016/0016-5085(93)90003-u. [DOI] [PubMed] [Google Scholar]
  15. Jen J., Kim H., Piantadosi S., Liu Z. F., Levitt R. C., Sistonen P., Kinzler K. W., Vogelstein B., Hamilton S. R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med. 1994 Jul 28;331(4):213–221. doi: 10.1056/NEJM199407283310401. [DOI] [PubMed] [Google Scholar]
  16. Jen J., Powell S. M., Papadopoulos N., Smith K. J., Hamilton S. R., Vogelstein B., Kinzler K. W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res. 1994 Nov 1;54(21):5523–5526. [PubMed] [Google Scholar]
  17. Jensen V., Ladekarl M., Holm-Nielsen P., Melsen F., Soerensen F. B. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol. 1995 Aug;176(4):343–352. doi: 10.1002/path.1711760405. [DOI] [PubMed] [Google Scholar]
  18. Joyeux C., Chalbos D., Rochefort H. Effects of progestins and menstrual cycle on fatty acid synthetase and progesterone receptor in human mammary glands. J Clin Endocrinol Metab. 1990 May;70(5):1438–1444. doi: 10.1210/jcem-70-5-1438. [DOI] [PubMed] [Google Scholar]
  19. Joyeux C., Rochefort H., Chalbos D. Progestin increases gene transcription and messenger ribonucleic acid stability of fatty acid synthetase in breast cancer cells. Mol Endocrinol. 1989 Apr;3(4):681–686. doi: 10.1210/mend-3-4-681. [DOI] [PubMed] [Google Scholar]
  20. Kearney J., Giovannucci E., Rimm E. B., Stampfer M. J., Colditz G. A., Ascherio A., Bleday R., Willett W. C. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control. 1995 Jan;6(1):45–56. doi: 10.1007/BF00051680. [DOI] [PubMed] [Google Scholar]
  21. Kuhajda F. P., Jenner K., Wood F. D., Hennigar R. A., Jacobs L. B., Dick J. D., Pasternack G. R. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6379–6383. doi: 10.1073/pnas.91.14.6379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kuhajda F. P., Piantadosi S., Pasternack G. R. Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. N Engl J Med. 1989 Sep 7;321(10):636–641. doi: 10.1056/NEJM198909073211003. [DOI] [PubMed] [Google Scholar]
  23. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  24. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991 Aug 9;253(5020):665–669. doi: 10.1126/science.1651563. [DOI] [PubMed] [Google Scholar]
  25. Paulauskis J. D., Sul H. S. Hormonal regulation of mouse fatty acid synthase gene transcription in liver. J Biol Chem. 1989 Jan 5;264(1):574–577. [PubMed] [Google Scholar]
  26. Pizer E. S., Wood F. D., Heine H. S., Romantsev F. E., Pasternack G. R., Kuhajda F. P. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res. 1996 Mar 15;56(6):1189–1193. [PubMed] [Google Scholar]
  27. Pizer E. S., Wood F. D., Pasternack G. R., Kuhajda F. P. Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res. 1996 Feb 15;56(4):745–751. [PubMed] [Google Scholar]
  28. Pope T. S., Smart D. A., Rooney S. A. Hormonal effects on fatty-acid synthase in cultured fetal rat lung; induction by dexamethasone and inhibition of activity by triiodothyronine. Biochim Biophys Acta. 1988 Mar 25;959(2):169–177. doi: 10.1016/0005-2760(88)90028-8. [DOI] [PubMed] [Google Scholar]
  29. Powell S. M., Petersen G. M., Krush A. J., Booker S., Jen J., Giardiello F. M., Hamilton S. R., Vogelstein B., Kinzler K. W. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med. 1993 Dec 30;329(27):1982–1987. doi: 10.1056/NEJM199312303292702. [DOI] [PubMed] [Google Scholar]
  30. Riddell R. H., Goldman H., Ransohoff D. F., Appelman H. D., Fenoglio C. M., Haggitt R. C., Ahren C., Correa P., Hamilton S. R., Morson B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983 Nov;14(11):931–968. doi: 10.1016/s0046-8177(83)80175-0. [DOI] [PubMed] [Google Scholar]
  31. Robey-Cafferty S. S., Ro J. Y., Ordonez N. G., Cleary K. R. Transitional mucosa of colon. A morphological, histochemical, and immunohistochemical study. Arch Pathol Lab Med. 1990 Jan;114(1):72–75. [PubMed] [Google Scholar]
  32. Shurbaji M. S., Kuhajda F. P., Pasternack G. R., Thurmond T. S. Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator. Am J Clin Pathol. 1992 May;97(5):686–691. doi: 10.1093/ajcp/97.5.686. [DOI] [PubMed] [Google Scholar]
  33. Smith S., Ryan P. Asynchronous appearance of two enzymes concerned with medium chain fatty acid synthesis in developing rat mammary gland. J Biol Chem. 1979 Sep 25;254(18):8932–8936. [PubMed] [Google Scholar]
  34. Tsao J., Shibata D. Further evidence that one of the earliest alterations in colorectal carcinogenesis involves APC. Am J Pathol. 1994 Sep;145(3):531–534. [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES